Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • hongyan
    Junior Member
    • Sep 2008
    • 3

    #1

    some questions about ChIP-Seq replicates/controls

    1. Design: Does ChIP-seq need biological replicates? Is control sample necessary?

    2. DNA shearing: If doing ChIP-chip, DNA fragments usually range from 500-600 bp. But when illumina make libraries, they start from DNA with ~200 bp . Do we need to shear DNA to ~200bp during ChIP?
  • Chipper
    Senior Member
    • Mar 2008
    • 323

    #2
    1. No. No. But of course multiple replicates and controls can give you more reliable data.

    2. It is possible even if the majority of reads are above the selected size, or to select larger fragments. But around 200 bp seems to be optimal for Illumina and SOLiD to get good number of reads and high resolution.

    Comment

    • hongyan
      Junior Member
      • Sep 2008
      • 3

      #3
      Hi, Chipper,
      Thanks for your reply.
      If my budget is enough for only two samples, which one should I choose: two biological replicates or one sample/ one control?

      As I understand, increasing the depth of sequencing enough for one sample may have the similar power as doing two biological replicates. Is it right?

      Comment

      • Chipper
        Senior Member
        • Mar 2008
        • 323

        #4
        One sample and one control or two samples. You can get god results from one lane and no control, but have to be aware that some regions may act strangely due to duplications etc. You can re-use the library to increase sequence depth later on, it should be cheaper than running two different libraries.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        31 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        38 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-13-2026, 09:56 AM
        0 responses
        31 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-09-2026, 11:14 AM
        0 responses
        29 views
        0 reactions
        Last Post SEQadmin2  
        Working...